The utility of TIM-1 as a marker for a proportion of human IL-10+ Bregs has been further confirmed in inflammatory and autoimmune diseases, such as in RA patients, who exhibit reduced frequencies of TIM-1+ Bregs (514). This evidence concerns the gene IL10 and autoimmune disease.